Hirotoshi Iihara Selected Research

Hirotoshi Iihara Research Topics

Disease

29	Nausea 06/2022 - 05/2009
28	Vomiting 06/2022 - 05/2009
25	Neoplasms (Cancer) 06/2022 - 05/2009
14	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 06/2011
10	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2022 - 10/2008
4	Peripheral Nervous System Diseases (PNS Diseases) 03/2022 - 10/2008
4	Breast Neoplasms (Breast Cancer) 03/2022 - 10/2008
4	Drug-Related Side Effects and Adverse Reactions 01/2022 - 06/2011
4	Lung Neoplasms (Lung Cancer) 01/2021 - 09/2012
4	Exanthema (Rash) 06/2016 - 03/2013
3	Anorexia 04/2022 - 05/2009
3	Pancreatic Neoplasms (Pancreatic Cancer) 08/2021 - 11/2018
3	Stomach Neoplasms (Stomach Cancer) 12/2020 - 10/2008
2	Cachexia 04/2022 - 12/2020
2	Pain (Aches) 03/2022 - 08/2021
2	Diarrhea 01/2019 - 06/2011
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 06/2022
1	Disorders of Excessive Somnolence (Hypersomnia) 03/2022
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 03/2021
1	Febrile Neutropenia 03/2021
1	Peritoneal Neoplasms 02/2020
1	Ileus 02/2020
1	Renal Cell Carcinoma (Grawitz Tumor) 11/2019
1	Dysgeusia (Parageusia) 11/2018
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2017
1	Adenocarcinoma of Lung 01/2017
1	Neoplasm Metastasis (Metastasis) 01/2017
1	Adenocarcinoma 01/2017
1	Meningeal Carcinomatosis 01/2017
1	Stomach Ulcer (Gastric Ulcer) 01/2015

Drug/Important Bio-Agent (IBA)

21	AntiemeticsIBA 06/2022 - 05/2009
12	Carboplatin (JM8)FDA LinkGeneric 03/2022 - 09/2012
10	Dexamethasone (Maxidex)FDA LinkGeneric 06/2022 - 12/2013
9	Olanzapine (Zyprexa)FDA Link 03/2022 - 12/2017
7	EmeticsIBA 01/2019 - 01/2013
6	Neurokinin-1 Receptor AntagonistsIBA 06/2022 - 01/2019
6	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022 - 06/2011
6	Granisetron (Kytril)FDA LinkGeneric 01/2021 - 05/2009
5	5-HT3 Serotonin Receptors (5 HT3 Receptor)IBA 03/2022 - 05/2009
5	Pharmaceutical PreparationsIBA 03/2022 - 12/2010
5	AfatinibIBA 11/2021 - 07/2016
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 03/2022 - 05/2009
4	AnthracyclinesIBA 03/2022 - 05/2009
4	Bevacizumab (Avastin)FDA Link 01/2021 - 06/2011
3	Cisplatin (Platino)FDA LinkGeneric 06/2022 - 12/2017
3	ErbB Receptors (EGF Receptor)IBA 11/2021 - 01/2017
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2021 - 10/2008
3	Monoclonal AntibodiesIBA 06/2016 - 11/2015
2	Serotonin (5 Hydroxytryptamine)IBA 06/2022 - 01/2020
2	Antineoplastic Agents (Antineoplastics)IBA 04/2022 - 08/2012
2	CreatinineIBA 04/2022 - 04/2020
2	Gemcitabine FDA Link 07/2021 - 11/2018
2	Aprepitant (Emend)FDA Link 02/2021 - 01/2020
2	Pemetrexed (MTA)FDA Link 01/2021 - 06/2015
2	SteroidsIBA 01/2021 - 11/2015
2	trifluridine tipiracil drug combinationIBA 01/2020 - 11/2019
2	Tyrosine Kinase InhibitorsIBA 01/2019 - 01/2017
2	polaprezinc (Z 103)IBA 11/2018 - 01/2015
2	azasetronIBA 01/2017 - 09/2012
2	Minocycline (Cyclops)FDA LinkGeneric 06/2016 - 11/2015
2	Panitumumab (Vectibix)FDA Link 02/2016 - 11/2015
1	pembrolizumabIBA 04/2022
1	Vinorelbine (Navelbine)FDA LinkGeneric 04/2022
1	Capecitabine (Xeloda)FDA Link 01/2022
1	Proton Pump InhibitorsIBA 01/2022
1	1- (5- (2- fluorophenyl)- 1- (pyridin- 3- ylsulfonyl)- 1H- pyrrol- 3- yl)- N- methylmethanamineIBA 01/2022
1	130-nm albumin-bound paclitaxelIBA 07/2021
1	regorafenibIBA 07/2021
1	AlbuminsIBA 07/2021
1	BilirubinIBA 07/2021
1	pegfilgrastim (Neulasta)FDA Link 03/2021
1	amrubicinIBA 03/2021
1	Drug CombinationsIBA 01/2021
1	afliberceptIBA 01/2021
1	NivolumabIBA 12/2020
1	osimertinibIBA 02/2020
1	Sunitinib (Sutent)FDA Link 11/2019
1	ZincIBA 11/2018
1	Prochlorperazine (Compazine)FDA LinkGeneric 12/2017
1	Antipsychotic Agents (Antipsychotics)IBA 12/2017
1	Irinotecan (Camptosar)FDA LinkGeneric 12/2016
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 07/2016
1	Gefitinib (Iressa)FDA Link 07/2016
1	Cetuximab (Erbitux)FDA Link 02/2016
1	Therapeutic UsesIBA 02/2016
1	SolutionsIBA 01/2015
1	AlginatesIBA 01/2015
1	drug combination magnesium hydroxide aluminum hydroxide (Maalox)IBA 01/2015

Therapy/Procedure

37	Drug Therapy (Chemotherapy) 04/2022 - 10/2008
17	Therapeutics 06/2022 - 01/2015
4	Combination Drug Therapy (Combination Chemotherapy) 07/2021 - 05/2009
2	Chemoradiotherapy 01/2017 - 01/2015
2	Injections 08/2012 - 06/2011
1	Radiotherapy 06/2022
1	Adjuvant Chemotherapy 04/2022
1	Renal Dialysis (Hemodialysis) 01/2017
1	Oral Administration 07/2016
1	Drug Tapering 02/2016
1	Skin Care 11/2015
1	Treatment Delay 01/2015